Naltrexone/Bupropion

FDA Meeting – Naltrexone/Bupropion (Contrave)

By Kate Ryan | Dec 7, 2010 | Comments Off on FDA Meeting – Naltrexone/Bupropion (Contrave)

Food and Drug Administration (FDA) Gastroenterology Endocrinologic and Metabolic Drugs Advisory Committee